This inventor holds 1 USPTO granted patent. Top assignee: Kunming University of Science and Technology. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations of Yingjun Zhang in Hepatitis B Treatment
Introduction
Yingjun Zhang is a notable inventor based in Kunming, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for hepatitis B. His innovative work has the potential to impact the lives of many suffering from liver diseases.
Latest Patents
Yingjun Zhang holds a patent for a sesquiterpene derivative, which is utilized in the preparation of a medicament for treating hepatitis B diseases. This sesquiterpene derivative is designed to down-regulate the hepatocyte nuclear factor 4α (HNF-4α) and significantly inhibit the hepatitis B virus. The invention can be used for preventing, treating, or assisting in the treatment of liver system diseases and symptoms caused by the hepatitis B virus. Additionally, it serves as a hepatic protective agent. The synthetic sesquiterpene derivative can also be applied in preventing or treating viral infectious diseases caused by various viruses, including the influenza virus and herpes simplex virus. The preparation of this derivative is suitable for various pharmaceutical formulations, including oral dosage forms like tablets and capsules, as well as non-oral forms such as inhalants and injections.
Career Highlights
Yingjun Zhang is affiliated with Kunming University of Science and Technology, where he conducts research and develops innovative solutions in the field of medicinal chemistry. His work has garnered attention for its potential applications in treating viral infections and liver diseases.
Collaborations
Yingjun Zhang collaborates with several colleagues, including Min Xu and Haoyang Yuan, to advance research and development in his field. Their combined efforts contribute to the innovative environment at Kunming University of Science and Technology.
Conclusion
Yingjun Zhang's contributions to the development of treatments for hepatitis B through his patented sesquiterpene derivative highlight his role as an influential inventor in the field of medicinal chemistry. His work not only addresses a critical health issue but also showcases the importance of innovation in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile